WallStreetZenWallStreetZen

NASDAQ: ASLN
Aslan Pharmaceuticals Ltd Earnings & Revenue

ASLN past revenue growth

How has ASLN's revenue growth performed historically?
Company
N/A
Industry
80.9%
Market
15.78%
ASLN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ASLN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ASLN earnings and revenue history

Current Revenue
$12.0M
Current Earnings
-$35.0M
Current Profit Margin
-291.9%

ASLN Return on Equity

Current Company
N/A
Current Industry
16.6%
Current Market
28.2%

Be the first to know when ASLN announces earnings.

ASLN Return on Assets

Current Company
-96.3%
Current Industry
3.1%
ASLN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ASLN Return on Capital Employed

Current Company
-2,237.16%
Current Industry
-43.5%
ASLN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASLN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ASLN$12.00MN/A-$35.03M+31.95%N/A
BRTX$145.80k-$14.16M-$14.42M+5.61%N/A
VCNX$124.00k-$19.07M-$19.19M-27.33%N/A
EFTR$0.00-$31.54M-$34.63M-100.00%N/A
CHRO$0.00-$7.88M-$8.98MN/AN/A

Aslan Pharmaceuticals Earnings & Revenue FAQ

What were ASLN's earnings last quarter?

On Invalid Date, Aslan Pharmaceuticals (NASDAQ: ASLN) reported Q1 2024 earnings per share (EPS) of -$0.50, up 60% year over year. Total Aslan Pharmaceuticals earnings for the quarter were -$9.92 million. In the same quarter last year, Aslan Pharmaceuticals's earnings per share (EPS) was -$1.25.

If you're new to stock investing, here's how to buy Aslan Pharmaceuticals stock.

What was ASLN's earnings growth in the past year?

As of Q2 2024, Aslan Pharmaceuticals's earnings has grown year over year. Aslan Pharmaceuticals's earnings in the past year totalled -$35.03 million.

What was ASLN's revenue last quarter?

On Invalid Date, Aslan Pharmaceuticals (NASDAQ: ASLN) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Aslan Pharmaceuticals's revenue was $0.00.

What was ASLN's revenue growth in the past year?

As of Q2 2024, Aslan Pharmaceuticals's revenue has grown null year over year. Aslan Pharmaceuticals's revenue in the past year totalled $12.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.